An overview of tuberculosis outbreaks reported in the years 2011-2020

BMC Infect Dis. 2023 Apr 20;23(1):253. doi: 10.1186/s12879-023-08197-w.

Abstract

Background: In many countries tuberculosis (TB) remains a highly prevalent disease and a major contributor to infectious disease mortality. The fight against TB requires surveillance of the population of strains circulating worldwide and the analysis of the prevalence of certain strains in populations. Nowadays, whole genome sequencing (WGS) allows for accurate tracking of TB transmission. Currently, there is a lack of a comprehensive summary of the characteristics of TB outbreaks.

Methods: We systematically analyzed studies reporting TB outbreaks worldwide, monitored through WGS of Mycobacterium tuberculosis. We 1) mapped the reported outbreaks from 2011- 2020, 2) estimated the average size of the outbreaks, 3) indicated genetic lineages causing the outbreaks, and 4) determined drug-resistance patterns of M. tuberculosis strains involved in the outbreaks.

Results: Most data originated from Europe, Asia, and North America. We found that TB outbreaks were reported throughout the globe, on all continents, and in countries with both high and low incidences. The detected outbreaks contained a median of five M. tuberculosis isolates. Most strains causing the outbreaks belonged to lineage four, more rarely to lineage two. Reported outbreak isolates were often drug resistant.

Conclusions: We conclude that more WGS surveillance of M. tuberculosis outbreaks is needed. Globally standardized procedures might improve the control of M. tuberculosis infections.

Keywords: Local outbreaks; Recent transmission; Tuberculosis; Tuberculosis transmission; Whole genome sequencing.

Publication types

  • Review

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Disease Outbreaks
  • Drug Resistance, Multiple, Bacterial
  • Genotype
  • Humans
  • Mutation
  • Mycobacterium tuberculosis*
  • Tuberculosis* / drug therapy
  • Tuberculosis, Multidrug-Resistant* / drug therapy

Substances

  • Antitubercular Agents